Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

New natural intergenotypic (2/5) recombinant of hepatitis C virus.

Legrand-Abravanel F, Claudinon J, Nicot F, Dubois M, Chapuy-Regaud S, Sandres-Saune K, Pasquier C, Izopet J.

J Virol. 2007 Apr;81(8):4357-62. Epub 2007 Jan 31.

2.

Antibodies to a novel antigen in acute hepatitis C virus infections.

Tobler LH, Stramer SL, Chien DY, Lin S, Arcangel P, Phelps BH, Cooper SL, Busch MP.

Vox Sang. 2007 Jan;92(1):1-7.

PMID:
17181584
3.

Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland.

Moreau I, Hegarty S, Levis J, Sheehy P, Crosbie O, Kenny-Walsh E, Fanning LJ.

Virol J. 2006 Nov 15;3:95.

4.

A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines.

Kageyama S, Agdamag DM, Alesna ET, LeaƱo PS, Heredia AM, Abellanosa-Tac-An IP, Jereza LD, Tanimoto T, Yamamura J, Ichimura H.

J Med Virol. 2006 Nov;78(11):1423-8.

PMID:
16998890
5.
6.

Absence of HCV viral recombination following superinfection.

Bernardin F, Herring B, Page-Shafer K, Kuiken C, Delwart E.

J Viral Hepat. 2006 Aug;13(8):532-7.

PMID:
16901283
7.

Identification of novel defective HCV clones in liver transplant recipients with recurrent HCV infection.

Iwai A, Marusawa H, Takada Y, Egawa H, Ikeda K, Nabeshima M, Uemoto S, Chiba T.

J Viral Hepat. 2006 Aug;13(8):523-31.

PMID:
16901282
8.

Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus.

Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, Haagmans BL.

J Virol. 2006 Aug;80(15):7569-77.

9.

Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes.

Aaskov J, Buzacott K, Thu HM, Lowry K, Holmes EC.

Science. 2006 Jan 13;311(5758):236-8.

10.

Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients.

Yagi S, Mori K, Tanaka E, Matsumoto A, Sunaga F, Kiyosawa K, Yamaguchi K.

J Med Virol. 2005 Nov;77(3):399-413.

PMID:
16173026
11.

Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies.

Lin S, Arcangel P, Medina-Selby A, Coit D, Ng P, Nguyen S, McCoin C, Gyenes A, Hu C, Tandeske L, Phelps B, Chien D.

J Clin Microbiol. 2005 Aug;43(8):3917-24.

12.

Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man.

Bowen DG, Walker CM.

J Exp Med. 2005 Jun 6;201(11):1709-14. Review.

13.

Acute-phase hepatitis C virus infection: implications for research, diagnosis, and treatment.

Busch MP, Shafer KA.

Clin Infect Dis. 2005 Apr 1;40(7):959-61. Epub 2005 Mar 3. No abstract available.

PMID:
15824986
14.

Immunology of hepatitis B virus and hepatitis C virus infection.

Rehermann B, Nascimbeni M.

Nat Rev Immunol. 2005 Mar;5(3):215-29. Review.

PMID:
15738952
15.

The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection?

Bowen DG, Walker CM.

J Hepatol. 2005 Mar;42(3):408-17. Review. No abstract available.

PMID:
15710225
16.
17.

CD8 epitope escape and reversion in acute HCV infection.

Timm J, Lauer GM, Kavanagh DG, Sheridan I, Kim AY, Lucas M, Pillay T, Ouchi K, Reyor LL, Schulze zur Wiesch J, Gandhi RT, Chung RT, Bhardwaj N, Klenerman P, Walker BD, Allen TM.

J Exp Med. 2004 Dec 20;200(12):1593-604.

18.

Genetic interactions between hepatitis C virus replicons.

Evans MJ, Rice CM, Goff SP.

J Virol. 2004 Nov;78(21):12085-9.

19.

Frequent hepatitis C virus superinfection in injection drug users.

Herring BL, Page-Shafer K, Tobler LH, Delwart EL.

J Infect Dis. 2004 Oct 15;190(8):1396-403. Epub 2004 Sep 8.

PMID:
15378431
20.

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.

Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP; National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group.

N Engl J Med. 2004 Aug 19;351(8):760-8.

Supplemental Content

Support Center